BehaveNet®
Clinical Capsule™

  
Join Our Mailing List

Email:

For Email Newsletters you can trust
Follow updates to BehaveNet with Twitter

drug: ramelteon

Clinical class hypnotic
Action melatonin receptor agonist
Chemical class tricyclic indan derivative
CSA schedule none
DEA number  
Routes of administration oral
Associated with (substance-related)  

 

 disorders: none
Availability prescription
MEDLINEplus® Drug Information
U.S. Preparations:

Rozerem™ (Takeda) FDA approved for treatment of :
7.22.2005 Insomnia characterized by difficulty with sleep onset
US prescribing information

Dose: 8 mg.
Color:  pale orange-yellow
Shape: round
Type: film-coated tablet
Imprint: "TAK"
"RAM-8"


http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2009 BehaveNet®